346 related articles for article (PubMed ID: 10187419)
1. The role of direct-to-consumer advertising.
Navarro RP
Manag Care Interface; 1998 Nov; 11(11):79-80, 82. PubMed ID: 10187419
[No Abstract] [Full Text] [Related]
2. Medicine goes Madison Avenue: an evaluation of the effect of direct-to-consumer pharmaceutical advertising on the learned intermediary doctrine.
Allen MC
Spec Law Dig Health Care Law; 1998 Dec; (236):9-29. PubMed ID: 10187553
[No Abstract] [Full Text] [Related]
3. Selling drugs to the public--should the UK follow the example of the US?
Frey J
Br J Gen Pract; 2002 Feb; 52(475):170-1. PubMed ID: 11885831
[No Abstract] [Full Text] [Related]
4. Major issues in marketing regulation.
Pines WL
Food Drug Law J; 1997; 52(3):297-302. PubMed ID: 10343028
[No Abstract] [Full Text] [Related]
5. Pharmaceuticals and medical devices: FDA oversight.
Berry MD
Issue Brief Health Policy Track Serv; 2013 Dec; ():1-123. PubMed ID: 24482893
[No Abstract] [Full Text] [Related]
6. Selling drugs to doctors--it's marketing, not education.
Cooper R; Hoffman J
Br J Gen Pract; 2002 Feb; 52(475):168-9. PubMed ID: 11885830
[No Abstract] [Full Text] [Related]
7. [Rules of the game in drug marketing].
Palva E
Duodecim; 1999; 115(20):2187, 2189. PubMed ID: 11973920
[No Abstract] [Full Text] [Related]
8. Direct-to-consumer marketing: the Food and Drug Administration is not alone.
Kalb PE; Dunlop KO; McEnroe DC; Stein SD
Food Drug Law J; 2003; 58(1):25-33. PubMed ID: 12739582
[No Abstract] [Full Text] [Related]
9. Direct-to-consumer prescription drug advertising.
Terzian TV
Am J Law Med; 1999; 25(1):149-67. PubMed ID: 10207573
[No Abstract] [Full Text] [Related]
10. Direct-to-consumer genetic tests, government oversight, and the First Amendment: what the government can (and can't) do to protect the public's health.
Javitt GH; Stanley E; Hudson K
Oklahoma Law Rev; 2004; 57(2):251-302. PubMed ID: 15658034
[No Abstract] [Full Text] [Related]
11. Claim substantiation in the health care industry.
Fergenson PE
Hosp Mater Manage Q; 1992 May; 13(4):20-6. PubMed ID: 10117377
[No Abstract] [Full Text] [Related]
12. The new drug marketing: a consumer protection perspective.
Woodward D
Food Drug Law J; 1996; 51(4):637-50. PubMed ID: 11797733
[No Abstract] [Full Text] [Related]
13. Big bad pharma: an ethical analysis of physician-directed and consumer-directed marketing tactics.
Connors AL
Albany Law Rev; 2009 Sep; 73(1):243-82. PubMed ID: 20235401
[No Abstract] [Full Text] [Related]
14. Experimenting with direct-to-consumer advertising.
Lancet; 2000 Aug; 356(9230):607. PubMed ID: 10968426
[No Abstract] [Full Text] [Related]
15. Problems associated with direct-to-consumer advertising (DTCA) of restricted, implantable medical devices: should the current regulatory approach be changed?
Patsner B
Food Drug Law J; 2009; 64(1):1-41. PubMed ID: 19998571
[TBL] [Abstract][Full Text] [Related]
16. To ban or not to ban--that is the question: the constitutionality of a moratorium on consumer drug advertising.
Schwartz MI
Food Drug Law J; 2008; 63(1):1-33. PubMed ID: 18561453
[No Abstract] [Full Text] [Related]
17. "Daddy, what is erectile dysfunction?" Direct-to-consumer advertising will be changing.
Feinberg DT
J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):866-8. PubMed ID: 16379506
[No Abstract] [Full Text] [Related]
18. Direct-to-consumer advertisements of prescription drugs.
Council on Ethical and Judicial Affairs of the American Medical Association
Food Drug Law J; 2000; 55(1):119-24. PubMed ID: 12322719
[No Abstract] [Full Text] [Related]
19. Understanding government regulation of the marketing and advertising of medical devices, drugs, and biologics: the challenges of the Internet.
Reichertz PS
Food Drug Law J; 1997; 52(3):303-8. PubMed ID: 10343029
[No Abstract] [Full Text] [Related]
20. Direct-to-consumer drug marketing: public service or disservice?
Berger JT; Kark P; Rosner F; Packer S; Bennett AJ
Mt Sinai J Med; 2001 May; 68(3):197-202. PubMed ID: 11373692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
